|
|
GMP Training Seminars
ComplianceNet, Inc. offers a variety of GMP
training courses to help your company achieve compliance with federal and
international regulations. We regularly present seminars at
international conferences. Visit the Upcoming Events page to
see when the next course is scheduled.
We can also bring these courses to you.
Instead of paying for travel and lodging for only one or two employees to
attend a conference, why not custom tailor a training seminar to fit your
needs and let everyone attend in the comfort of your own conference
room?
The following courses are currently
available. Customizations of these courses or additional courses can
also be arranged. Email us for more
information.
 |
API
GMP Compliance: Training on ICH Q7A. Focuses on the
specific, detailed FDA and international recommendations on
how to apply GMPs that are missing from the more generic
Finished Products regulations.
|
 |
Building in Compliance,
Analytical Laboratories: How to set up an Analytical
Laboratory so it can be fully GMP compliant, yet still retain its
efficiency. Differences are pointed out for labs working on
early phase clinical products vs. marketed products.
|
 |
Building in
Compliance, Process Development: How to ensure that Process
Development work can be captured in a GMP compliant manner so it can
be used to support product filing claims and process validation.
|
 |
21 CFR
Part 11 Compliance: How to apply the Electronic Record and
Electronic Signature regulations in your environment and key
pitfalls to avoid. Includes an overview of the regulation and
how it applies to various applications, spreadsheets, network
environments, etc.
|
|
|
FDA on
Training |
| Training and Education
are one of the best preventive and responsive investments a firm can
make!
Training should be an integral and fundamental
thread that holds the success of your firm’s programs together to
assure conformance to the act.
Be sure training programs reflect current practices
and procedures.
Keep abreast of what others may be doing.
Steven Niedelman, FDA Presentation at
PDA October
2002 |
|
 |